HomeNAUT • NASDAQ
add
Nautilus Biotechnology Inc
Previous close
$2.51
Day range
$2.40 - $2.71
Year range
$0.62 - $3.08
Market cap
307.55M USD
Avg Volume
208.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.42M | -22.80% |
Net income | -13.78M | 21.67% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -15.02M | 22.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.41M | -20.39% |
Total assets | 191.11M | -21.27% |
Total liabilities | 34.14M | 0.37% |
Total equity | 156.97M | — |
Shares outstanding | 126.56M | — |
Price to book | 2.02 | — |
Return on assets | -19.67% | — |
Return on capital | -20.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -13.78M | 21.67% |
Cash from operations | -12.38M | 13.52% |
Cash from investing | 787.00K | -97.88% |
Cash from financing | 101.00K | -77.05% |
Net change in cash | -11.49M | -149.43% |
Free cash flow | -7.14M | 22.81% |
About
Founded
2016
Headquarters
Website
Employees
130
